Bis--peroxid | 1886-68-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Bis--peroxid
• 英文别名: p-Toluolsulfonylperoxid；Di-(p-methyl)phenyl-sulfonyl-peroxid；1,1'-(Peroxydisulfonyl)bis(4-methylbenzene)；(4-methylphenyl)sulfonyloxy 4-methylbenzenesulfonate
• CAS: 1886-68-6
• 化学式: C₁₄H₁₄O₆S₂
• 分子量: 342.394
• InChiKey: YGTVRIJNXGNYDR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  104
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• LUMINESCENT COMPOUNDS
  申请人：Patsenker D. Leonid

  公开号：US20070281363A1

  公开（公告）日：2007-12-06

  Reporter compounds based on cyanine dyes, among others, including reactive intermediates used to synthesize the reporter compounds, and methods of synthesizing and using the reporter compounds, among others, where the reporter compounds relate generally to the following structure:

  基于青菁染料的报告化合物，其中包括用于合成报告化合物的反应中间体，以及合成和使用报告化合物的方法，其中报告化合物通常与以下结构相关：
• EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE
  申请人：ExxonMobil Research and Engineering Company

  公开号：US20170158521A1

  公开（公告）日：2017-06-08

  A novel synthetic crystalline material, EMM-28, can be synthesized in the presence of an organic structure directing agent (Q) selected from one or more of the following dications: EMM-28 may be used in organic compound conversion reactions and sorptive processes.

  一种新型合成晶体材料EMM-28，可在存在有机结构定向剂（Q）的情况下合成，该剂可从以下一种或多种双阳离子中选择：EMM-28可用于有机化合物转化反应和吸附过程。
• 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
  申请人：Pfizer Inc.

  公开号：US10738063B2

  公开（公告）日：2020-08-11

  The present invention is directed to PDE4B inhibitors of Formula I: (I) or a pharmaceutically acceptable salt thereof, wherein the substituents R1, R2, R3, and R4 are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.

  本发明涉及式 I 的 PDE4B 抑制剂：（I）或其药学上可接受的盐，其中取代基 R1、R2、R3 和 R4 如本文所定义。 本发明还涉及包含这些化合物的药物组合物、使用这些化合物的治疗方法以及制备这些化合物的方法。
• METHOD FOR CONTINUOUS CURING OF HIPE INTO HIPE FOAMS
  申请人：THE PROCTER & GAMBLE COMPANY

  公开号：EP1169374A1

  公开（公告）日：2002-01-09
• 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS
  申请人：Pfizer Inc.

  公开号：US20190300546A1

  公开（公告）日：2019-10-03

  The present invention is directed to PDE4B inhibitors of Formula I: (I) or a pharmaceutically acceptable salt thereof, wherein the substituents R 1 , R 2 , R 3 , and R 4 are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.